Cut-points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practice. Hazan J, Liu KY, Isaacs JD, Howard R, et al. Alzheimers Dement 2025;21:e70113.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hazan J, Liu KY, Isaacs JD, Howard R, et al. Cut-points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practice. Alzheimers Dement 2025;21:e70113.
PMID: 40145267